Anti-BORG4/ CDC42EP4/ CEP4 monoclonal antibody

Anti-BORG4/ CDC42EP4/ CEP4 antibody for FACS & in-vivo assay

Target products collectionGo to CDC42EP4/CDC42EP4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2045-Ab-1/ GM-Tg-hg-MP2045-Ab-2Anti-Human CDC42EP4 monoclonal antibodyHuman
GM-Tg-rg-MP2045-Ab-1/ GM-Tg-rg-MP2045-Ab-2Anti-Rat CDC42EP4 monoclonal antibodyRat
GM-Tg-mg-MP2045-Ab-1/ GM-Tg-mg-MP2045-Ab-2Anti-Mouse CDC42EP4 monoclonal antibodyMouse
GM-Tg-cynog-MP2045-Ab-1/ GM-Tg-cynog-MP2045-Ab-2Anti-Cynomolgus/ Rhesus macaque CDC42EP4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2045-Ab-1/ GM-Tg-felg-MP2045-Ab-2Anti-Feline CDC42EP4 monoclonal antibodyFeline
GM-Tg-cang-MP2045-Ab-1/ GM-Tg-cang-MP2045-Ab-2Anti-Canine CDC42EP4 monoclonal antibodyCanine
GM-Tg-bovg-MP2045-Ab-1/ GM-Tg-bovg-MP2045-Ab-2Anti-Bovine CDC42EP4 monoclonal antibodyBovine
GM-Tg-equg-MP2045-Ab-1/ GM-Tg-equg-MP2045-Ab-2Anti-Equine CDC42EP4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2045-Ab-1/ GM-Tg-hg-MP2045-Ab-2; GM-Tg-rg-MP2045-Ab-1/ GM-Tg-rg-MP2045-Ab-2;
GM-Tg-mg-MP2045-Ab-1/ GM-Tg-mg-MP2045-Ab-2; GM-Tg-cynog-MP2045-Ab-1/ GM-Tg-cynog-MP2045-Ab-2;
GM-Tg-felg-MP2045-Ab-1/ GM-Tg-felg-MP2045-Ab-2; GM-Tg-cang-MP2045-Ab-1/ GM-Tg-cang-MP2045-Ab-2;
GM-Tg-bovg-MP2045-Ab-1/ GM-Tg-bovg-MP2045-Ab-2; GM-Tg-equg-MP2045-Ab-1/ GM-Tg-equg-MP2045-Ab-2
Products NameAnti-CDC42EP4 monoclonal antibody
Formatmab
Target NameCDC42EP4
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CDC42EP4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species BORG4/ CDC42EP4/ CEP4 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP002593human CDC42EP4 Lentivirus particle
    ORF Viral VectorpGMLP002593human CDC42EP4 Lentivirus plasmid
    ORF Viral VectorpGMLPm001963mouse Cdc42ep4 Lentivirus plasmid
    ORF Viral VectorvGMLPm001963mouse Cdc42ep4 Lentivirus particle


    Target information

    Target IDGM-MP2045
    Target NameCDC42EP4
    Gene ID23580,56699,303653,696227,475907,101092563,540152,100061186
    Gene Symbol and Synonyms1500041M20Rik,BORG4,CDC42EP4,CEP4,KAIA1777
    Uniprot AccessionQ9H3Q1
    Uniprot Entry NameBORG4_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000179604
    Target ClassificationN/A

    The target: CDC42EP4, gene name: CDC42EP4, also named as BORG4, CEP4, KAIA1777. The product of this gene is a member of the CDC42-binding protein family. Members of this family interact with Rho family GTPases and regulate the organization of the actin cytoskeleton. This protein has been shown to bind both CDC42 and TC10 GTPases in a GTP-dependent manner. When overexpressed in fibroblasts, this protein was able to induce pseudopodia formation, which suggested a role in inducing actin filament assembly and cell shape control. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.